Zantac
In October 2019, a class-action lawsuit was filed against Sanofi for allegedly misleadingly marketing the over-the-counter heartburn medication Zantac as safe when, according to plaintiffs, the medicine contains dangerously high levels of the carcinogen N-nitrosodimethylamine (NDMA). (Rodriguez et al v. Sanofi U.S. LLC et al, Case No. 19-cv-9527, S. D. NY.)
Class-Action Tracker
The Latest
Olive Tree People
These “waterless” beauty products contain some surprising ingredients.
The Struggle is (Not) Real
Rags-to-riches stories on repeat.
Giant Bicycles’ ‘Shipping Fee’
TINA.org finds bike maker peddling misleading online prices.
Lean Cuisine Salisbury Steak
Beef isn’t the only meat on the menu.
Roblox ads enticed, targeted kids as young as 5 to try caffeinated potato chips, watchdog says
Lisa Fickenscher, The New York Post